Cuscal (CCL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
28 May, 2026Executive summary
NPAT for the half year ended 31 December 2025 rose 76% to $21.5m, with underlying NPAT up 13% to $24.2m, reflecting strong operational growth and the impact of the Indue acquisition.
Transaction volume increased 9% year-over-year, supported by robust segment performance and Indue integration.
Completed the acquisition of Indue on 1 December 2025, contributing $5.3m to Net Operating Income and expected to deliver significant cost synergies and EPS accretion.
Interim dividend of 4.5 cents per share declared, fully franked, consistent with the prior year.
Maintained a strong capital position and AA- credit rating.
Financial highlights
Net operating income grew 10% year-over-year to $161.5m, including a $5.3m contribution from Indue.
Underlying NPAT increased 13% to $24.2m; statutory NPAT rose 76% to $21.5m.
EPS increased 4% to 12.6 cents, reflecting a higher share count post-IPO.
Operating expenses rose 10% to $127.5m, mainly due to higher employee costs and technology investment.
Underlying NPAT margin improved to 15% for 1H FY26.
Outlook and guidance
Full-year outlook raised: high single-digit transaction volume growth expected to drive mid-teens underlying NPAT growth for FY26.
First half earnings projected to represent about 55% of full-year underlying NPAT due to seasonally strong H1.
Indue integration expected to deliver over 20% return on invested capital and $15–20m annual post-tax cost synergies by FY29.
Statutory EPS expected to be dilutive for the first two years post-acquisition due to integration timing.
Focus remains on product expansion, risk management, and Indue integration.
Latest events from Cuscal
- Pro forma NPAT up 42% to $21.5m, EBITDA up 21%, and transaction volumes up 7% in H1 FY25.CCL
H1 202528 May 2026 - FY25 NPAT beat forecasts; Indue acquisition to deliver major synergies and EPS growth.CCL
H2 202528 May 2026 - Profit up 21% to $31.6m, dividend increased, and IPO targeted for late 2024.CCL
H2 202425 Mar 2026 - Strong H1 FY25 growth and innovation position the business for further expansion.CCL
ASX SMIDcaps Conference Presentation8 Oct 2025